acromegaly, pituitary gland, somatotropin, type 2 diabetes mellitus


In Ukraine, primary diagnosis of orphan diseases is extremely low. In general, this is explained by the insufficient awareness of primary care doctors, the difficulties of diagnosing acromegaly (АМ). The majority of patients seek help at the stage of development of a bright clinical picture of AM. That is why family doctors and doctors of other specialties (therapists, dentists, endocrinologists, neurosurgeons, orthopedists, cardiologists) need to be highly informed in order to suspect and diagnose the disease in time.



Melmed S., Bronstein M.D., Chanson P.A. et al. Consensus Statement on acromegaly therapeutic outcomes. Nat Rev Endocrinol 2018. 14(9). Р. 552-561. DOI:

Horvath E., Kovacs K. Pathology of acromegaly. Neuroendo-crinology. 2006. No. 83(3-4). P. 161-165. DOI:

Kannan S., Kennedy L. Diagnosis of acromegaly: state of the art. Expert. Opin. Med. Diagn. 2013 Sep. No. 7(5). P. 443-53. DOI: https://10.1517/17530059.2013.820181.

Daly A.F., Tichomirowa M.A., Beckers A. The epidemiology and genetics of pituitary adenomas. Best. Pract. Res. Clin. Endocrinol. Metab. 2009 Oct. No. 23(5). H. 543-54. DOI: https://10.1016/j.beem.2009.05.008.

Nilsson B., Gustavasson-Kadaka E., Bengtsson B.A., Jonsson B. Pituitary adenomas n Sweden between 1958 and 1991: incidence, survival, and mortality. J. Clin. Endocrinol. Metab. 2000 Apr. No. 85(4). P. 1420-5.

Daly A.F., Burlacu M.C., Livadariu E., Beckers A. The epidemiology and management of pituitary incidentalomas. Horm Res. 2007. 68. Suppl 5. P. 195-8. DOI: https://10.1159/000110624.

Lavrentaki A, Paluzzi A, Wass JA, Karavitaki N. Epidemiology of acromegaly: review of population studies. Pituitary. 2017 Feb;20(1):4-9. DOI: https://10.1007/s11102-016-0754-x.

Maione L, Chanson P. National acromegaly registries. Best Pract Res Clin Endocrinol Metab. 2019 Apr. No. 33(2). 101264. DOI: https://10.1016/j.beem.2019.02.001.

Khyzhnyak O., Mykytyuk M., Guk M., Nikolaiev R., Gogitidze T. Clinical and hormonal features of acromegaly in patients from a Ukrainian neuroendocrinology centre. Probl. Endocr. Pathol. 2019. No. 68. P. 119-130. DOI: https://10.21856/j-PEP.2019.2.17.

Mercieca C., Gruppetta M., Vassallo J. Epidemiology, treatment trends and outcomes of acromegaly. Eur. J. Intern. Med. 2012 Dec. No. 23(8). P. 206-7. DOI: https://10.1016/j.ejim.2012.07.010.

Lavrentaki A., Paluzzi A., Wass J.A. et al. Epidemiology of acromegaly: review of population studies. Pituitary. 2017 Feb. No. 20(1). P. 4-9. DOI: https://10.1007/s11102-016-0754-x.

Bernabeu I., Aller J., Álvarez-Escolá C. et al. Criteria for diagnosis and postoperative control of acromegaly, and screening and management of its comorbidities: Expert consensus. Endocrinol Diabetes Nutr. 2018. No. 65(5). P. 297-305. DOI: https://10.1016/j.endinu.2018.01.008.

Petrossians P., Tichomirowa M.A., Stevenaert A. et al. The Liege Acromegaly Survey (LAS): anewsoftwaretool for the study of acromegaly. Ann. Endocrinol. (Paris). 2012. No. 73(3). P. 190-201. DOI: https://10.1016/j.ando.2012.05.001.

Bolanowski M., Zatonska K., Kaluzny M., et al. A follow-up of 130 patients with acromegaly in a single centre. Neuro. Endocrinol. Lett. 2006. No. 27(6). P. 828-832.

Fernandez A., Karavitaki N., Wass J.A. Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury. Clin Endocrinol (Oxf). 2010 Mar. No. 72(3). P. 377-82. DOI: https://10.1111/j.1365-2265.2009.03667.

Molitvoslovova N., Przhiyalkovskaya E., Rozhinskaya L., Melnichenko G. Russian register of patients with hypothalamo-hypophyseal disorders: update to May 2010. In: Abstract book of 14th Con-gress of ENEA. Liege. 2010. No. 58. P. 119.

Sesmilo G., Webb S.M. Twelve years of the Spanish acro-megaly registry: a historical view of acromegaly management in Spain. Endocrinol. Nutr. 2010 Feb. No. 57(2). P. 39-42. DOI: https://10.1016/j.en-donu.2010.01.003.

Vandeva S, Andreeva M, Orbetsova M, et al. Acromegaly in Bulgaria – Epidemiological characteristics of acromegaly in the Bulgarian population. Endocrinologia Jrnl. 2010. (3). Р. 142-150.

Katznelson L., Laws E.R., Melmed S., Molitch M.E., Murad M.H. et al. Acromegaly: an endocrine society clinical practice guideline. J. Clin. Endocrinol Metab. 2014 Nov. No. 99(11). P. 3933-51. DOI: https://10.1210/jc.2014-2700.

Melmed S., Bronstein M.D., Chanson P., Klibanski A., Casanueva F.F. et al. A Consensus Statement on acromegaly therapeutic outcomes. Nat. Rev. Endocrinol. 2018 Sep. No. 14(9). Р. 552-61. DOI: https://10.1038/s41574-018-0058-5.

Тронько М.Д., Кваченюк А.М., Луценко Л.А., Супрун І.С., Охрімчук О.О. Орфанні захворювання в онкоендокринології (огляд літератури й власні дані). Практична онкологія. 2020. № 3(2). С. 5-17. DOI:

Bolanowski M., Adnan Z., Doknic M., Guk M., Hána V., Ilovayskaya I. et al. Acromegaly: Clinical Care in Central and Eastern Europe, Israel, and Kazakhstan. Front Endocrinol (Lausanne). 22.02.2022. 13:816426. DOI: https://10.3389/fendo.2022.816426.

Giustina A., Barkan A., Beckers A. і співавт.: A consensus on the diagnosis and treatment of acromegaly comorbidities: an update. J. Clin. Endocrinol. Metab., 2019; 10. DOI: 10.1210/clinem/dgz096.

Lewiński A. Endokrynologia – postępy 2019/2020. Med. Prakt. 2020. No. 6. Р. 78–89.

Тронько М.Д, Кваченюк А.М, Луценко Л.А, Супрун І.С., Охрімчук О.О. Орфанні захворювання в ендокринології. Ендокринологія. 14.12.2020. № 25(4). С.327-42. DOI: https://10.31793/1680-1466.2020.25-4.327.

Тронько М.Д, Караченцев Ю.І., Кваченюк А.М., Хижняк О.О., Гук М.О., Возняк О.М., Луценко Л.А. Проблема акромегалії в Україні. Створення Всеукраїнського національного Реєстру хворих на акромегалію та аналіз попередніх даних. Ендокринологія. 2022. № 27(2). С. 96-105. DOI:



How to Cite

Hradyk Т., & Tsysnetska А. (2022). ACROMEGALY: CURRENT PROBLEMS IN UKRAINE. Actual Problems of Medicine and Pharmacy, 3(2), 1–8.